Company Profile

Brighton Development (AKA: Genomex)
Profile last edited on: 1/29/18      CAGE: 47R90      UEI: RYCEB8HU2U77

Business Identifier: Sterilization packaging
Year Founded
1999
First Award
2003
Latest Award
2021
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

1306 Walnut Street
Cary, NC 27511
   (919) 467-1473
   pollyman4u@aol.com
   N/A
Location: Single
Congr. District: 04
County: Wake

Public Profile

Brighton Development is developing sterilization packaging such as disposable bags and labware. The firm's technology involves the development of antimicrobial plastics. Particular products under development include self-sterilizing bags and pouches and self-sterilizing materials for common contact surfaces such as tables and certain lab instruments

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2021 2 NIH $1,190,332
Project Title: Novel Low Temperature Sterilization Method for Flexible Endoscopes
2017 2 NIH $1,834,883
Project Title: Simple Self-Contained Self-Sterilizing Bag
2017 2 NIH $1,118,089
Project Title: Unique Antimicrobial Catheter to Prevent Urinary Tract Infections
2012 2 NIH $1,093,007
Project Title: Permanent Antimicrobial Medical Plastic
2003 1 NIH $98,827
Project Title: Genomic Labware with Protein 'Non-Stick' Surfaces

Key People / Management

  Joel L Williams -- President

Company News

There are no news available.